Posted: Thurs., Dec. 24, 1992

RSS
Email Author
Print Article
Email Article
Digg
Discussions

Financial Briefs

Spelling Entertainment Group Inc. said its subsidiary Aaron Spelling Productions Inc. is calling for redemption of the remaining $ 12.5 million principal amount of its outstanding 12.25% subordinated notes due Aug. 1, 1993. The redemption date is Feb. 1, 1993.

Under the terms of the notes, the company will pay 100% of the principal amount of each note redeemed. The regular semi-annual interest payment will be paid on Feb. 1, and interest on the notes will no longer accrue after Feb. 1.

Carmike Cinemas Inc.'s common stock is now listed on the New York Stock Exchange under the stock symbol "CKE," as of yesterday. The Georgia-based exhibitors' shares had previously been traded on the NASDAQ.

Blockbuster Entertainment Corp. said it has filed a $ 300 million debt shelf registration statement with the Securities & Exchange Commission. The company said it intends that any net proceeds from the sale of such securities would be used to repay outstanding debt, to fund future acquisitions and for general corporate purposes. The company also announced it has completed the formation of its previously announced joint venture with the Virgin Retail Group.

TALKBACK:

Have an opinion about this article? Be the first to comment


Q What are the top 3 things affecting our industry today?
A. Daena - 1.) The internet 2.) HD Technology 3.) The impending recessionmore >


Submit this form
Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.